NSECopy of Newspaper Publication▲ PositiveResults12 Aug 2026
Camlin Fine Sciences Limited
Copy of Newspaper Publication
Camlin Fine Sciences Limited has published un-audited financial results for the quarter ended June 30, 2026, showing a net profit of Rs. 219 crores, with a basic EPS of Rs. 0.31 and a diluted EPS of Rs. 0.31.
BSECompany Update▲ PositiveResults12 Aug 2026
Bata India Ltd
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Bata India Limited has informed about Investors Presentation
Bata India Ltd has submitted an investors presentation for its Q1 FY27 results, highlighting growth in retail sales, expansion of its digital channels, and improvements in inventory management.
BSECompany Update▲ PositiveResults12 Aug 2026
Royal Orchid Hotels Ltd
Pursuant to Regulation 30 read with Part A Schedule III of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, and in continuation to our letter dated August 10, ....
Royal Orchid Hotels Ltd announced its Q1 FY27 performance, with a 36.1% YoY increase in income from operations, 39.1% YoY increase in EBITDA, and 11.7 CR in cash profit. The company's occupancy rate was 70.6% and ARR was ₹6,233 (+13.6% YoY). Iconiqa, a hotel operated by the company, achieved critical milestones and was rated No 1 hotel on Trip Advisor in Mumbai within 4 months of operation.
BSECompany Update▲ PositiveResults12 Aug 2026
Aster DM Quality Care Ltd
Transcript of earning conference call held for the quarter ended 30 June 2026
Aster DM Quality Care Ltd, a healthcare company, held its first earnings conference call for Q1 FY27, discussing its operational and financial performance. The company has unified two healthcare leaders into a single platform, with a focus on elevating clinical excellence, expanding geographic access, and driving patient-centric innovation.
BSEBoard Meeting▲ PositiveResults12 Aug 2026
Shukra Pharmaceuticals Ltd
Quartely results June 30, 2026
Shukra Pharmaceuticals Ltd has announced its quarterly results for the period ended June 30, 2026, with a net profit of ₹1,502.98 lakhs. The company's revenue from operations was ₹2,352.23 lakhs, and its total income from operations was ₹2,406.20 lakhs. The results have been reviewed by the Audit Committee and approved by the Board of Directors.
NSEInvestor Presentation▲ PositiveResults12 Aug 2026
Grasim Industries Limited
Investor Presentation
Grasim Industries Limited has informed the Exchange about Investor Presentation for Q1FY27, presenting unaudited financial results for the quarter ended 30th June 2026, with consolidated revenue at ₹48,716 Cr. up 21% YoY, driven by strong all-round performance across its diversified businesses portfolio.
BSECompany Update▲ PositiveResults12 Aug 2026
Grasim Industries Ltd
Presentation on Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2026
Grasim Industries Ltd presented its unaudited financial results for Q1FY27, showing a 21% YoY increase in consolidated revenue to ₹48,716 Cr, driven by strong performance across its diversified businesses. Standalone revenue reached an all-time high of ₹11,795 Cr, up 28% YoY. Consolidated EBITDA stood at ₹8,077 Cr, up 26% YoY, driven by revenue-led growth and cost efficiencies.
NSEInvestor Presentation▲ PositiveResults12 Aug 2026
Royal Orchid Hotels Limited
Investor Presentation
Royal Orchid Hotels Limited has released its Q1 FY27 investor presentation, highlighting a 36.1% year-over-year increase in consolidated income from operations and a 39.1% year-over-year increase in EBITDA.
BSECompany Update▲ PositiveResults12 Aug 2026
Grasim Industries Ltd
Press Release on the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended 30th June 2026
Grasim Industries Ltd announced its unaudited financial results for Q1FY27, with consolidated revenue at ₹48,716 Cr., up 21% YoY, driven by strong all-round performance across its diversified businesses portfolio. EBITDA stood highest-ever at ₹8,077 Cr., up 26% YoY, and adjusted PAT stood at ₹2,153 Cr., up 49% YoY.
NSEPress Release▲ PositiveResults12 Aug 2026
Grasim Industries Limited
Press Release
Grasim Industries Limited announced its unaudited financial results for Q1FY27, with consolidated revenue reaching ₹48,716 Cr., up 21% YoY, driven by strong all-round performance across its diversified businesses portfolio. EBITDA stood at ₹8,077 Cr., up 26% YoY, and adjusted PAT stood at ₹2,153 Cr., up 49% YoY.
NSEOutcome of Board Meeting▲ PositiveResults12 Aug 2026
Indo Count Industries Limited
Outcome of Board Meeting
Indo Count Industries Limited has submitted its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, which were approved by the Board of Directors on August 12, 2026. The results show a profit before tax of Rs. 8,350.94 crore and a profit for the period of Rs. 6,322.44 crore. The company's earnings per share (EPS) for the quarter is Rs. 3.19.
NSEInvestor Presentation▲ PositiveResults12 Aug 2026
Kusumgar Limited
Investor Presentation
Kusumgar Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue up 102% YoY to ₹2,472 Mn, driven by execution ramp-up on finished parachutes contracts. The company has also highlighted its expertise in engineered fabrics, particularly in polyamides, polyester filaments, and polyurethane chemistry, with a focus on high-performance requirements of customers.
BSEResult▲ PositiveResults12 Aug 2026
Sahyadri Industries Ltd
As per attachment
Sahyadri Industries Ltd announced its unaudited financial results for Q1 FY 2027, declaring an interim dividend of INR 2.50 per equity share. The company reported a profit of INR 35.50 crore from ordinary activities before taxes, with segment-wise profit before tax and interest from each segment being INR 34.95 crore. The company's total assets stood at INR 554.85 crore, with segment-wise assets being INR 423.21 crore and INR 29.10 crore for Building Material and Power Generation segments, respectively.
NSEOutcome of Board Meeting▲ PositiveResults12 Aug 2026
Sahyadri Industries Limited
Outcome of Board Meeting
Sahyadri Industries Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a net profit of INR 35.50 crores. The company has also declared an interim dividend of INR 2.50 per share for the financial year 2026-27.
NSEOutcome of Board Meeting▲ PositiveResults12 Aug 2026
Lokesh Machines Limited
Outcome of Board Meeting
Lokesh Machines Limited has submitted its financial results for the quarter ended June 30, 2026, with a net profit of Rs. 101.01 lakhs. The company's standalone un-audited financial results show a revenue from operations of Rs. 5,577.40 lakhs and expenses of Rs. 5,436.08 lakhs, resulting in a profit before tax of Rs. 141.32 lakhs. The company's earnings per share (EPS) is Rs. 0.49 for the quarter.
BSEBoard Meeting▲ PositiveResults12 Aug 2026
Rama Vision Ltd
Outcome of the Board Meeting dated 12th August, 2026
Rama Vision Ltd has announced its standalone unaudited financial results for the quarter ended June 30, 2026, with a profit of Rs. 209.01 lakhs from continuing operations. The company has also reported a profit of Rs. 592.46 lakhs for the year ended March 31, 2026. The results include a revenue from operations of Rs. 15,875.46 lakhs and a total income of Rs. 15,917.12 lakhs for the year ended March 31, 2026.
NSEOutcome of Board Meeting▲ PositiveResults12 Aug 2026
Hindustan Aeronautics Limited
Outcome of Board Meeting
Hindustan Aeronautics Limited has submitted its audited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 158.06 crores.
BSECompany Update▲ PositiveResults12 Aug 2026
Sai Parenterals Ltd
Investor Presentation Q1 FY 2027
Sai Parenterals Ltd has disclosed its investor presentation for Q1 FY 2027, highlighting its global IP-led pharmaceutical platform, integrated CDMO and branded generics enterprise, and long-term contracted international revenue. The company has a strong R&D-driven CDMO engine, with a 7.5-year exclusive OTC supply agreement in Australia and a 4-year exclusive anti-tuberculosis contract in the Philippines.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults12 Aug 2026
Sai Life Sciences Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Sai Life Sciences Limited has informed the Exchange about the Transcript of the Earnings conference call organized on 07 August 2026, post declaration of the Un-audited Financial Results of the Company for the quarter ended 30 June 2026.
BSECompany Update▲ PositiveResults12 Aug 2026
Godrej Agrovet Ltd
Please find enclosed transcript of conference call with the Investors and Analysts held on August 6, 2026
Godrej Agrovet Ltd reported Q1 FY27 earnings with consolidated sales of INR2,852 crores, a 10% year-on-year growth, driven by strong performance in Animal Nutrition and Oil Palm segments, despite a challenging operating environment.